Klyv meets CSIR India delegation at Oslo Science Park

Klyv Therapeutics was among a small group of Norwegian biotech companies to meet Dr N. Kalaiselvi, Director General of India’s Council of Scientific and Industrial Research (CSIR), and her delegation during a visit to Forskningsparken – Oslo Science Park. Klyv’s COO Hanne Th. Bonge-Hansen took part in the discussions, alongside representatives from other companies based […]

Klyv presents during a royal visit to Oslo Science Park

Klyv founder and CEO Maria Vistnes presented the company’s cardiac fibrosis drug development work to Crown Prince Haakon and Prince Sverre Magnus during a royal visit to Forskningsparken – Oslo Science Park. The presentation took place at Startuplab, the early-stage investor and start-up community based at the park. The visit was part of a wider […]

Klyv welcomes Hanne Th. Bonge-Hansen as COO

Klyv Therapeutics has appointed Hanne Th. Bonge-Hansen as Chief Operating Officer (COO). She joins the company as it continues to grow its team and advance its work on new treatments for cardiac fibrosis and heart failure. Hanne holds a PhD in organic chemistry and is also an EQE-qualified European Patent Attorney, with experience spanning drug […]

Klyv secures pre-seed funding round

Klyv Therapeutics has secured a pre-seed funding round, with investments from Aleap Ventures, Startuplab, and a group of angel investors. Alongside grants awarded to the company, the round marks an important step in Klyv’s early development. The funding allows Klyv to take its work forward in lead optimization — the stage of designing and refining […]

Klyv accepted into the Nordic Mentor Network for Entrepreneurship (NOME)

Klyv Therapeutics has been accepted into the Nordic Mentor Network for Entrepreneurship (NOME). CEO Maria Vistnes represented the company as one of six finalists at the NOME Annual Meeting, where she was awarded this year’s pitch prize. NOME is an elite mentoring programme for life science start-ups across the Nordic region, established in 2016 and […]